AIM: To evaluate the clinical outcomes of the retrogasserian opioid application in patients with type 1 trigeminal neuralgia.
The pain occurs in an area where the fifth cranial nerve is scattered, and it is characterized by sudden attacks without additional neurological deficits (2) . The pain can occur in the first, second, or third branches of the nerve. In addition, it can also be present in several branches of the nerve. It is generally felt as a one-sided pain. Nevertheless, it can also be two-sided (10, 20) . The TN form accompanying systemic diseases such as multiple sclerosis is referred to as secondary TN. The TN form that does not accompany any disease is termed primary or idiopathic TN (11) (12) (13) .
Recently, TN has been accepted as a neuropathic form of pain. Some irritative pathologies can cause TN in the middle fossa, cavernous cortex, and peripheral area (9) .
According to the guidelines of the American Academy of Neurology and the European Federation of Neurological Societies, carbamazepine and oxcarbazepine are recommended as firstline medical treatments for pain control in patients with TN (6). However, minimally invasive treatment methods and surgical treatments can also be applied to patients who do not receive benefit from medical treatments. Minimally invasive treatment methods for TN are percutaneous controlled rhizotomy, glycerol rhizotomy, and percutaneous balloon compression. Surgical treatments are microvascular decompression and gamma knife radiosurgery (8, 12, 14, 15, 18) .
Opioids are the most effective medical agents that can be used to treat acute and chronic pain. In previous studies,
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In our study, the efficiency of the combination of bupivacaine and fentanyl on the Gasser ganglion blockage in idiopathic TN patients was examined.
█ MATERIAL and METHODS
Ethics committee approval was received for this study from KTO University, Medicana Faculty of Medicine (Decision No. 2018-18). Informed consent forms were obtained from all patients.
In our retrospective study, recordings of 37 patients who were administered due to type 1 TN between February 2012 and May 2015 were examined. There were 12 male and 25 female patients. Sixty percent of the patients had pain on the right side, and 40% had pain on the left side.
Blockage treatment was administered to patients who had been under carbamazepine treatment more than 2 years and who were evaluated as normal according to results from brain magnetic resonance imaging. Visual analogue scale (VAS) scores obtained preoperatively and at the last visit were recorded.
Surgical Procedure
The patient was placed in the supine position. A thin roll was placed under the patient's head, and the patient was brought to 15 degrees of extension. The patient was lightly sedated with propofol. The patient's blood pressure, blood oxygen saturation, and cardiac function were monitored. The perioral area was sterilized. Local anaesthesia was administered with lidocaine at the entry point of the cannula, 2.0 cm lateral of the labial commissure. Using a 30-gauge long dental needle, the tip was directed to the intersection of the plane passing through the pupil and the plane passing parallel to the ~2.0 cm lateral area of the meatus acusticus externus. It was noted that the needle did not perforate the oral mucosa. The needle was directed toward the foramen ovale, and continuous images were taken using fluoroscopy to visualize its position. Because the preganglionic (retrogasser) fibers of the Gasser ganglion were at the level of the petroclival angle, it was noted that the needle did not go beyond this point. After the appearance of cerebrospinal fluid (CSF), 3 mL of local anaesthetic agent consisting of 2 cc bupivacaine and 1 mL prilocaine in addition to 1 mL fentanyl and 1 mL betamethasone disodium phosphate Celestone ® was injected. After, the needle was removed, and the procedure was ended (Figure 1 ).
Cold compress application was performed to decrease oedema, which can occur in the chin after the operation. Patients were discharged one day after the operation.
Statistical Analysis
Statistical analysis was performed using the Wilcoxon signed-rank and Mann-Whitney U tests with the help of the SPSS program (18.0 for Windows). A p value of <0.05 was considered statistically significant.
█ RESULTS
Of the 37 patients, 12 were men and 25 were women, and their mean age was 56.2 ± 5.4 years. The mean VAS pain scores of patients decreased from 7.9 ± 0.62 at the initial presentation to 2.9 ± 0.5 at the last postoperative visit (p<0.01). The mean follow-up period was 15.6 months (median: 13 months).
In this series, no mortality or major complications (anaesthesia dolorosa, permanent corneal reflex loss, transient cranial nerve weakness, CSF fistula, meningitis, etc.) were observed. The procedure was repeated twice in 6 patients and 3 times in 2 patients. 
█ DISCUSSION
TN is a disorder characterized by sudden onset, lightning flash, short duration, and paroxysmal pain attacks in the area of distribution of one or more branches of the trigeminal nerve. There is no cranial nerve or neurological disorder other than pain (1, 4) . Primary treatment of TN is medical. However, surgical treatment can be performed when medical treatment is inadequate. Percutaneous methods such as glycerol rhizotomy, trigeminal radiofrequency rhizotomy (RFT), and balloon compression can be used (3) . Furthermore, surgical methods such as microvascular decompression can also be employed. The choice of the treatment method in TN changes according to the age and general health status of the patient, as well as the severity of the pain and the status of compliance with the medical treatment (19) .
The glycerol rhizotomy procedure is performed in trigeminal cisternae by glycerol injection. It is essentially a destructive application. Its pain control is inadequate; however, the complication rate is higher (7, 21) . RFT is based on the principle that the slowly formed thermal lesion causes damage in trigeminal root pain fibres. Compared with other percutaneous methods, it has been found that the recurrence is less likely and pain control is better. The reason for this is that thermal injury is more effective than chemical and mechanical injuries. However, severe complications such as corneal anaesthesia, anaesthesia dolorosa and neuroparalytic keratitis have been observed after RFT application (10) .
Opioids are drugs commonly used in the treatment of acute and chronic pain. Fentanyl is a synthetic opioid and is quite lipophilic. It acts through µ receptors. Recently, fentanyl has been used as a patch in the treatment of many chronic pain types (17) . Furthermore, it has been used for the treatment of type 2 TN in the sphenopalatine ganglion blockade, for which successful outcomes were obtained (5) .
In our study, retrogasserian opioid injection was administered to patients with type 1 TN. A significant improvement was observed in the VAS pain scores of the patients, and no major complication was noted.
The primary limitation of the present study is its retrospective nature. However, the present findings may contribute to the percutaneous treatment of TN.
█ CONCLUSION
This study shows that opioid injection to the gasserian ganglion is an efficient and safe technique in the short and medium term, and it can be efficiently applied to patients with type 1 TN.
